Using blood tests to guide lung cancer care
Part of Cancer, Lungs & breathing clinical trials.
This trial uses a simple blood test (liquid biopsy) to find tumor DNA in people suspected of having lung cancer. The goal is to learn if this test can help doctors make better treatment decisions without needing a tissue sample.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- Your doctor suspects you may have lung cancer
- You have not had another type of cancer in the last 5 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a blood test to look for tiny genetic markers (miRNA and DNA methylation) that may help detect lung cancer early. If you have a lung nodule or mass found on a CT scan and haven't had treatment yet, you may be able to join.
This study tests whether a simple blood test (liquid biopsy) can help find lung cancer earlier in people at high risk. It also includes people already diagnosed with lung cancer to refine the test.
This study looks at whether combining lung images with a blood test (DNA methylation) can help find lung cancer early. It is for people who have a new diagnosis of lung cancer and have not had treatment yet, as well as for people without cancer as a comparison.
This study is testing whether certain markers in your blood or tissue can help find lung cancer early. It is for people who have lung cancer that can be removed by surgery and haven't had treatment yet.
This study uses a simple blood test (liquid biopsy) to find early signs of lung cancer in people who are at risk. It aims to catch lung cancer earlier, when it may be easier to treat.
This study checks whether a blood test (a liquid biopsy) can be used along with standard lung cancer screening to find lung cancer early in people at higher risk. It may help see if the blood test is practical and useful for screening—without needing symptoms.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.